We operate a free-to-view policy, asking only that you register in order to read all of our content. Please login or register to view the rest of this article.
ARTICLE · 08 MARCH 2016
Amgen Launches Enbrel Biosimilar Patent Litigation
Foley & Lardner LLP
Although Sandoz' application for FDA approval to market a biosimilar version of ENBREL® (etanercept) has yet to be approved, Amgen has brought suit under the Patent Act...
United StatesIntellectual Property








